Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Autism clinical trials now open on the TrialWire Platform

ADELAIDE, AUS, Jan 5, 2022 - (ACN Newswire) - TrialWire(TM) is pleased to announce new Autism (ASD) clinical studies are now available on the TrialWire Platform.

More than 6 million people have used TrialWire over the past few years to find clinical trials that are right for them at clinics and specialist centers near them.

The ASD studies on TrialWire are available in Australia, New Zealand, and the U.S.

They include studies for children, teenagers and adults around ASD possible causes, and managing symptoms that can impact people's lives.

You can search for a study near you and find your local specialist team here. https://www.autism-localresearchfinder.com/asd-research-enrolling/ Then see if you are eligible and apply instantly.

TrialWire is the most secure and accessible digital clinical trial search platform which is powered by HIPAA compliant Salesforce Health Cloud.

People can search for a clinical trial, check their eligibility and apply instantly. The Platform connects people with Study Coordinators at clinics so they can discuss their condition and eligibility and potentially join a study that is right for them.

Importantly, patient information is only shared with the clinic selected by the applicant. It is not shared, sold or reused to enroll patients in other studies.

TrialWire uses advanced algorithms and AI-Match to find people online who are interested in specific medical conditions. These people have proven to be highly motivated for both enrollment and retention. The biggest challenge to finding cures for medical conditions is that people who might benefit, don't know there is a trial on near them that could be right for them.

Most clinical trials either fail to enroll enough patients or need to extend enrollment timelines adding significant time and cost.

TrialWire provides a rapid and secure enrolment solution that benefits patients and sponsors.

TrialWire Platform sources clinical trial information from leading Government databases of approved clinical trials.

Find an ASD clinical trial near you today. Places for most clinical trials are limited. Clinical trials can offer advanced check-ups, advice and care as well as access to the latest therapies in research. https://www.autism-localresearchfinder.com/asd-research-enrolling/

About TrialWire(TM)

TrialWire(TM) is the leading digital patient recruitment platform for Sponsors and CROs requiring a rapid study recruitment boost.

Unlike all other recruitment tools, TrialWire uses advanced algorithms to find people when they are searching for health solutions online and, within 2 minutes, AI-Matches them with studies near them (or for DCTs) and connects them directly with the relevant site.

TrialWire Study Dashboards for Sponsors, CROs and Study Coordinators are powered by Salesforce Health Cloud providing the most secure and informative insights across the entire recruitment process.

Source: TrialWire

Copyright 2022 ACN Newswire . All rights reserved.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.